+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Direct-to-Consumer Genetic Testing Market Research Report by Type, by Result, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 4968843
  • Report
  • July 2021
  • Region: Global
  • 189 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The Global Direct-to-Consumer Genetic Testing Market will Grow to USD 3,253.44 Million by 2026, at a CAGR of 17.02%

FEATURED COMPANIES

  • 23andMe, Inc.
  • Ancestry.com LLC
  • Dante Labs, Inc.
  • Gene By Gene Ltd.
  • Helix
  • Living DNA
  • MORE
The Global Direct-to-Consumer Genetic Testing Market size was estimated at USD 1,266.61 Million in 2020 and expected to reach USD 1,477.98 Million in 2021, at a Compound Annual Growth Rate (CAGR) 17.02% to reach USD 3,253.44 Million by 2026.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Direct-to-Consumer Genetic Testing to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Type, the Direct-to-Consumer Genetic Testing Market was studied across Mitochondrial DNA Testing, Single Nucleotide Polymorphism Testing, and Y Chromosome Testing.
  • Based on Channel, the Direct-to-Consumer Genetic Testing Market was studied across Offline and Online.
  • Based on Result, the Direct-to-Consumer Genetic Testing Market was studied across Ancestry & Ethnicity, Cancer Screening, Genetic Disease Carrier Status, New Baby Screening, Traits, and Wellness. The Cancer Screening is further studied across Hereditary Cancer and Sporadic Cancer.
  • Based on Region, the Direct-to-Consumer Genetic Testing Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Direct-to-Consumer Genetic Testing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Direct-to-Consumer Genetic Testing Market, including 23andMe, Inc., 24Genetics, AlphaBiolabs Ltd, Ancestry.com LLC, Atlas Biomed, Chengdu 23Mofang Biotechnology Co., Ltd., Color, Dante Labs, Inc., EasyDNA, Family Tree DNA, Full Genomes Corporation, Inc., Gene By Gene Ltd., Genebase Systems, Genesis HealthCare, Helix, Identigene, L.L.C., Karmagenes, Laboratory Corporation of America, Inc., Living DNA, Mapmygenome, MyHeritage Ltd., Myriad Genetics, Inc., Pathway Genomics, Positive Biosciences, Ltd., Quest Diagnostics Incorporated, Shuwen Biotech Co. Ltd., Vitagene, Inc., and Xcode Life Sciences Pvt Ltd.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Direct-to-Consumer Genetic Testing Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Direct-to-Consumer Genetic Testing Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Direct-to-Consumer Genetic Testing Market?
4. What is the competitive strategic window for opportunities in the Global Direct-to-Consumer Genetic Testing Market?
5. What are the technology trends and regulatory frameworks in the Global Direct-to-Consumer Genetic Testing Market?
6. What is the market share of the leading vendors in the Global Direct-to-Consumer Genetic Testing Market?
7. What modes and strategic moves are considered suitable for entering the Global Direct-to-Consumer Genetic Testing Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 23andMe, Inc.
  • Ancestry.com LLC
  • Dante Labs, Inc.
  • Gene By Gene Ltd.
  • Helix
  • Living DNA
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Type Outlook
3.4. Channel Outlook
3.5. Result Outlook
3.6. Region Outlook
3.7. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Paradigm shift among consumers seeking greater control over their own healthcare
5.1.1.2. Rising awareness about genome testing and risk of genetic diseases
5.1.1.3. High aging population coupled with growing prevalence of chronic disorders
5.1.1.4. Increased inquisitiveness about the assessment of lineage and ancestry
5.1.2. Restraints
5.1.2.1. Related scientific, technical, and clinical issues
5.1.2.2. First amendment issues of honesty, fidelity to facts, and truth-in-advertising
5.1.3. Opportunities
5.1.3.1. Next-generation sequencing and bio-chip for present and future genetic diagnosis
5.1.3.2. Development of online applications to serve customer needs
5.1.4. Challenges
5.1.4.1. Complexity of test result interpretation
5.1.4.2. Lack of adequate physician knowledge about genetics and potential for genetic discrimination
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Direct-to-Consumer Genetic Testing Market, by Type
6.1. Introduction
6.2. Mitochondrial DNA Testing
6.3. Single Nucleotide Polymorphism Testing
6.4. Y Chromosome Testing

7. Direct-to-Consumer Genetic Testing Market, by Channel
7.1. Introduction
7.2. Offline
7.3. Online

8. Direct-to-Consumer Genetic Testing Market, by Result
8.1. Introduction
8.2. Ancestry & Ethnicity
8.3. Cancer Screening
8.3.1. Hereditary Cancer
8.3.1.1. Blood Cancer
8.3.1.2. Breast Cancer
8.3.1.3. Ovarian Cancer
8.3.2. Sporadic Cancer
8.4. Genetic Disease Carrier Status
8.5. New Baby Screening
8.6. Traits
8.7. Wellness

9. Americas Direct-to-Consumer Genetic Testing Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Direct-to-Consumer Genetic Testing Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Thailand

11. Europe, Middle East & Africa Direct-to-Consumer Genetic Testing Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. 23andMe, Inc.
13.2. 24Genetics
13.3. AlphaBiolabs Ltd
13.4. Ancestry.com LLC
13.5. Atlas Biomed
13.6. Chengdu 23Mofang Biotechnology Co., Ltd.
13.7. Color
13.8. Dante Labs, Inc.
13.9. EasyDNA
13.10. Family Tree DNA
13.11. Full Genomes Corporation, Inc.
13.12. Gene By Gene Ltd.
13.13. Genebase Systems
13.14. Genesis HealthCare
13.15. Helix
13.16. Identigene, L.L.C.
13.17. Karmagenes
13.18. Laboratory Corporation of America, Inc.
13.19. Living DNA
13.20. Mapmygenome
13.21. MyHeritage Ltd.
13.22. Myriad Genetics, Inc.
13.23. Pathway Genomics
13.24. Positive Biosciences, Ltd.
13.25. Quest Diagnostics Incorporated
13.26. Shuwen Biotech Co. Ltd.
13.27. Vitagene, Inc.
13.28. Xcode Life Sciences Pvt Ltd

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2020 (USD MILLION)
FIGURE 3. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2020 (USD MILLION)
FIGURE 4. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY RESULT, 2020 (USD MILLION)
FIGURE 5. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY REGION, 2020 (USD MILLION)
FIGURE 6. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 7. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET: MARKET DYNAMICS
FIGURE 8. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 9. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2020 VS 2026 (%)
FIGURE 10. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2020 VS 2026 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2026
FIGURE 12. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MITOCHONDRIAL DNA TESTING, 2018-2026 (USD MILLION)
FIGURE 13. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MITOCHONDRIAL DNA TESTING, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 14. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SINGLE NUCLEOTIDE POLYMORPHISM TESTING, 2018-2026 (USD MILLION)
FIGURE 15. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SINGLE NUCLEOTIDE POLYMORPHISM TESTING, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 16. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY Y CHROMOSOME TESTING, 2018-2026 (USD MILLION)
FIGURE 17. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY Y CHROMOSOME TESTING, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 18. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2020 VS 2026 (%)
FIGURE 19. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2020 VS 2026 (USD MILLION)
FIGURE 20. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2026
FIGURE 21. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY OFFLINE, 2018-2026 (USD MILLION)
FIGURE 22. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY OFFLINE, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 23. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ONLINE, 2018-2026 (USD MILLION)
FIGURE 24. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ONLINE, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 25. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY RESULT, 2020 VS 2026 (%)
FIGURE 26. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY RESULT, 2020 VS 2026 (USD MILLION)
FIGURE 27. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY RESULT, 2026
FIGURE 28. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ANCESTRY & ETHNICITY, 2018-2026 (USD MILLION)
FIGURE 29. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ANCESTRY & ETHNICITY, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 30. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, 2018-2026 (USD MILLION)
FIGURE 31. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 32. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, 2018-2026 (USD MILLION)
FIGURE 33. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 34. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BLOOD CANCER, 2018-2026 (USD MILLION)
FIGURE 35. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BLOOD CANCER, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 36. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BREAST CANCER, 2018-2026 (USD MILLION)
FIGURE 37. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BREAST CANCER, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 38. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY OVARIAN CANCER, 2018-2026 (USD MILLION)
FIGURE 39. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY OVARIAN CANCER, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 40. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SPORADIC CANCER, 2018-2026 (USD MILLION)
FIGURE 41. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SPORADIC CANCER, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 42. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY GENETIC DISEASE CARRIER STATUS, 2018-2026 (USD MILLION)
FIGURE 43. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY GENETIC DISEASE CARRIER STATUS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 44. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NEW BABY SCREENING, 2018-2026 (USD MILLION)
FIGURE 45. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NEW BABY SCREENING, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 46. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TRAITS, 2018-2026 (USD MILLION)
FIGURE 47. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TRAITS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 48. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY WELLNESS, 2018-2026 (USD MILLION)
FIGURE 49. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY WELLNESS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 50. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 51. ARGENTINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 52. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 53. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 54. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 55. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 56. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 57. AUSTRALIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 58. CHINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 59. INDIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 60. INDONESIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 61. JAPAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 62. MALAYSIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 63. PHILIPPINES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 64. SINGAPORE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 65. SOUTH KOREA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 66. THAILAND DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 67. EUROPE, MIDDLE EAST & AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 68. FRANCE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 69. GERMANY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 70. ITALY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 71. NETHERLANDS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 72. QATAR DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 73. RUSSIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 74. SAUDI ARABIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 75. SOUTH AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 76. SPAIN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 77. UNITED ARAB EMIRATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 78. UNITED KINGDOM DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 79. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET: FPNV POSITIONING MATRIX
FIGURE 80. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 81. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET, BY TYPE

List of Tables
TABLE 1. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 5. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MITOCHONDRIAL DNA TESTING, BY REGION, 2018-2026 (USD MILLION)
TABLE 6. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SINGLE NUCLEOTIDE POLYMORPHISM TESTING, BY REGION, 2018-2026 (USD MILLION)
TABLE 7. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY Y CHROMOSOME TESTING, BY REGION, 2018-2026 (USD MILLION)
TABLE 8. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CHANNEL, 2018-2026 (USD MILLION)
TABLE 9. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY OFFLINE, BY REGION, 2018-2026 (USD MILLION)
TABLE 10. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ONLINE, BY REGION, 2018-2026 (USD MILLION)
TABLE 11. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY RESULT, 2018-2026 (USD MILLION)
TABLE 12. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ANCESTRY & ETHNICITY, BY REGION, 2018-2026 (USD MILLION)
TABLE 13. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CANCER SCREENING, BY REGION, 2018-2026 (USD MILLION)
TABLE 14. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEREDITARY CANCER, BY REGION, 2018-2026 (USD MILLION)
TABLE 15. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BLOOD CANCER, BY REGION, 2018-2026 (USD MILLION)
TABLE 16. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2026 (USD MILLION)
TABLE 17. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY OVARIAN CANCER, BY REGION, 2018-2026 (USD MILLION)
TABLE 18. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SPORADIC CANCER, BY REGION, 2018-2026 (USD MILLION)
TABLE 19. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY GENETIC DISEASE CARRIER STATUS, BY REGION, 2018-2026 (USD MILLION)
TABLE 20. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NEW BABY SCREENING, BY REGION, 2018-2026 (USD MILLION)
TABLE 21. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TRAITS, BY REGION, 2018-2026 (USD MILLION)
TABLE 22. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY WELLNESS, BY REGION, 2018-2026 (USD MILLION)
TABLE 23. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 24. ARGENTINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 25. BRAZIL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 26. CANADA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 27. MEXICO DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 28. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 29. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 30. AUSTRALIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 31. CHINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 32. INDIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 33. INDONESIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 34. JAPAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 35. MALAYSIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 36. PHILIPPINES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 37. SINGAPORE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 38. SOUTH KOREA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 39. THAILAND DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 40. EUROPE, MIDDLE EAST & AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 41. FRANCE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 42. GERMANY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 43. ITALY DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 44. NETHERLANDS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 45. QATAR DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 46. RUSSIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 47. SAUDI ARABIA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 48. SOUTH AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 49. SPAIN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 50. UNITED ARAB EMIRATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 51. UNITED KINGDOM DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 52. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET: SCORES
TABLE 53. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET: BUSINESS STRATEGY
TABLE 54. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET: PRODUCT SATISFACTION
TABLE 55. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET: RANKING
TABLE 56. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 57. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET: MERGER & ACQUISITION
TABLE 58. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 59. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 60. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET: INVESTMENT & FUNDING
TABLE 61. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 62. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • 23andMe, Inc.
  • 24Genetics
  • AlphaBiolabs Ltd
  • Ancestry.com LLC
  • Atlas Biomed
  • Chengdu 23Mofang Biotechnology Co., Ltd.
  • Color
  • Dante Labs, Inc.
  • EasyDNA
  • Family Tree DNA
  • Full Genomes Corporation, Inc.
  • Gene By Gene Ltd.
  • Genebase Systems
  • Genesis HealthCare
  • Helix
  • Identigene, L.L.C.
  • Karmagenes
  • Laboratory Corporation of America, Inc.
  • Living DNA
  • Mapmygenome
  • MyHeritage Ltd.
  • Myriad Genetics, Inc.
  • Pathway Genomics
  • Positive Biosciences, Ltd.
  • Quest Diagnostics Incorporated
  • Shuwen Biotech Co. Ltd.
  • Vitagene, Inc.
  • Xcode Life Sciences Pvt Ltd
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll